SCHEMBL366324

SCHEMBL366324

C=CS(=O)(=O)c1cccc(Nc2c(S(=O)(=O)O)c3c(c4ccc(S(=O)(=O)O)cc24)C(=O)NC3=O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STK10 O94804 4/20 0.35
▸ SLK Q9H2G2 4/20 0.35
▸ SNCA P37840 1/20 0.34
▸ GSK3B P49841 7/20 0.32
▸ BRAF P15056 2/20 0.32
▸ NSD2 O96028 1/20 0.31
▸ DUSP3 P51452 1/20 0.31
▸ PTPN5 P54829 1/20 0.31
▸ CASP7 P55210 1/20 0.31
▸ CASP6 P55212 1/20 0.31
▸ PTPN11 Q06124 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ GNG2 P59768 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL16937435 0.87 STK10 (0.33) STK10SLK
SCHEMBL3678283 0.83 SNCA (0.35) STK10SLKSNCAGSK3BBRAF
SCHEMBL170997 0.70 ALDH1A1 (0.41) NSD2DUSP3PTPN5CASP6PTPN11
SCHEMBL5766206 0.62 CDK4 (0.42) GSK3BCASP7CASP6CASP3
SCHEMBL7034713 0.62 TNNI3K (0.39) ALDH1A1MAPK1HSD17B10
SCHEMBL6865288 0.62 SNCA (0.72) SNCANSD2DUSP3PTPN5CASP7
SCHEMBL10972252 0.62 CA1 (0.50) SNCAALDH1A1HSD17B10
SCHEMBL7838585 0.61 CA1 (0.42) SNCAALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL9717494 0.61 SNCA (0.76) SNCANSD2DUSP3PTPN5CASP7
SCHEMBL54845 0.61 TSHR (0.50) ALDH1A1MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6600017-B1 Peptide for use in diagnosing alzheimer's disease THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-07-29 — — US claimed
EP-2913402-B1 Retrovirus detection TOCAGEN INC (US) 2017-10-18 — — EP disclosed
US-9663834-B2 Retrovirus detection TOCAGEN INC. (US) 2017-05-30 — — US disclosed
EP-2913402-A1 Retrovirus detection Tocagen Inc. (US) 2015-09-02 — — EP disclosed
US-20130266931-A1 RETROVIRUS DETECTION TOCAGEN INC. (US) 2013-10-10 — — US disclosed
EP-2580325-A2 RETROVIRUS DETECTION Tocagen Inc. (US) 2013-04-17 — — EP disclosed
WO-2012009711-A2 RETROVIRUS DETECTION TOCAGEN INC. (US) 2012-01-19 — — WO disclosed
US-20070238096-A1 Hybrid energy transfer for nucleic acid detection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2007-10-11 — — US disclosed
WO-2007103558-A2 HYBRID ENERGY TRANSFER FOR NUCLEIC ACID DETECTION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-09-13 — — WO disclosed
US-6770448-B2 CONTACTING A SAMPLE WITH AN AGGREGATING AMYLOID A BETA PEPTIDE TO WHICH IS COVALENTLY BONDED A FLUORESCENT LABEL AND DETECTING THE FLUORESCENT LABEL IN ASSOCIATION WITH SUCH SAMPLE AS AN INDICATION OF AN AMYLOID AGGREGATE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-08-03 — — US disclosed
US-6600017-B1 Peptide for use in diagnosing alzheimer's disease THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-07-29 — — US disclosed
Send feedback